Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 701–800 of 1,001
Martineau, É., Arbour, D., Vallée, J., & Robitaille, R. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1748-18.2020 · Cited by 49
Haidet-Phillips, A. M., & Maragakis, N. J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.035 · Cited by 49
Vargas, M. R., Burton, N. C., Gan, L., Johnson, D. A., Schäfer, M., Werner, S., & Johnson, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056625 · Cited by 54
Differential pattern of brain‐specific CSF proteins tau and amyloid‐beta in Parkinsonian syndromes
Süssmuth, S. D., Uttner, I., Landwehrmeyer, B., Pinkhardt, E. H., Brettschneider, J., Petzold, A., Kramer, B., Schulz, J. B., Palm, C., Otto, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.22895 · Cited by 47
Bowerman, M., Vincent, T., Scamps, F., Perrin, F. E., Camu, W., & Raoul, C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00214 · Cited by 46
Fujioka, Y., Ishigaki, S., Masuda, A., Iguchi, Y., Udagawa, T., Watanabe, H., Katsuno, M., Ohno, K., & Sobue, G. (2013) · Scientific Reports · doi:10.1038/srep02388 · Cited by 46
The evolving biology of cell reprogramming
Wilmut, I., Sullivan, G. J., & Chambers, I. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0051 · Cited by 49
Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis
Kjældgaard, A.-L., Pilely, K., Olsen, K. S., Pedersen, S. W., Lauritsen, A. Ø., Møller, K., & Garred, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.007 · Cited by 53
Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
Mitchell, R. M., Lee, S. Y., Randazzo, W. T., Simmons, Z., & Connor, J. R. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-6 · Cited by 48
Targeting angiogenin in therapy of amyotropic lateral sclerosis
Kishikawa, H., Wu, D., & Hu, G.-F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1229 · Cited by 51
Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
Tosolini, A. P., & Sleigh, J. N. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00405 · Cited by 52
Capotondo, A., Milazzo, R., Garcia-Manteiga, J. M., Cavalca, E., Montepeloso, A., Garrison, B. S., Peviani, M., Rossi, D. J., & Biffi, A. (2017) · Science Advances · doi:10.1126/sciadv.1701211 · Cited by 45
Nanoparticle-Based Strategies to Treat Neuro-Inflammation
Poupot, R., Bergozza, D., & Fruchon, S. (2018) · Materials · doi:10.3390/ma11020270 · Cited by 52
Advances in stem cell therapy for amyotrophic lateral sclerosis
Mazzini, L., Ferrari, D., Anđjus, P. R., Bużańska, L., Cantello, R. M., Marchi, F. D., Gelati, M., Giniatullin, R. A., Glover, J. C., Grilli, M., et al. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1503248 · Cited by 50
Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS
Zeldich, E., Chen, C.-D., Boden, E., Howat, B., Nasse, J. S., Zeldich, D., Lambert, A. G., Yuste, A., Cherry, J. D., Mathias, R., et al. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01356-2 · Cited by 49
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
Association of Lead Exposure with Survival in Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Stallone, L., Richards, M., Hu, H., & Sandler, D. P. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11193 · Cited by 46
Li, C., Chen, Y., Chen, X., Wei, Q., Cao, B., & Shang, H. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00160 · Cited by 45
“…death, autophagy INTRODUCTION Amyotrophic lateral sclerosis (ALS) is a common fatal motor neuron disease characterized by selective degeneration of upper and lower motor neurons (Boillee et al., 2006; Kiernan et al., 2011; Turner et al., 2011) leading to progressive muscle atrophy and weakness.”
BackgroundNeuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
Balistreri, C. R., & Monastero, R. (2023) · Brain Sciences · doi:10.3390/brainsci14010019 · Cited by 51
Genetic approaches to study glial cells in the rodent brain
Pfrieger, F. W., & Slezak, M. (2012) · Glia · doi:10.1002/glia.22283 · Cited by 45
Jamilloux, Y., Pierini, R., Querenet, M., Juruj, C., Fauchais, A., Jauberteau, M., Jarraud, S., Lina, G., Etienne, J., Roy, C. R., et al. (2013) · Glia · doi:10.1002/glia.22454 · Cited by 44
The Role of the Innate Immune System in ALS
Phani, S., Ré, D. B., & Przedborski, S. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00150 · Cited by 51
The Endocannabinoid System in Amyotrophic Lateral Sclerosis
Bilsland, L. G., & Greensmith, L. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740081 · Cited by 48
Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS
Hirano, K., Ohgomori, T., Kobayashi, K., Tanaka, F., Matsumoto, T., Natori, T., Matsuyama, Y., Uchimura, K., Sakamoto, K., Takeuchi, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066969 · Cited by 46
Prion-like mechanisms in amyotrophic lateral sclerosis
Ayers, J. I., & Cashman, N. R. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00018-0 · Cited by 46
Massenzio, F., Peña‐Altamira, E., Petralla, S., Virgili, M., Zuccheri, G., Miti, A., Polazzi, E., Mengoni, I., Piffaretti, D., & Monti, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.013 · Cited by 49
The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 51
Argueti-Ostrovsky, S., Alfahel, L., Kahn, J., & Israelson, A. (2021) · Cells · doi:10.3390/cells10092438 · Cited by 48
ALS: life and death in a bad neighborhood
Monk, P. N., & Shaw, P. J. (2006) · Nature Medicine · doi:10.1038/nm0806-885 · Cited by 45
Pehar, M., Beeson, G., Beeson, C. C., Johnson, J. A., & Vargas, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103438 · Cited by 44
Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats
Lepore, A. C., Tolmie, C., O'Donnell, J., Wright, M. C., Dejea, C. M., Rauck, B. M., Höke, A., Ignagni, A. R., Onders, R. P., & Maragakis, N. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.021 · Cited by 46
Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice
Yamasaki, R., Tanaka, M., Fukunaga, M., Tateishi, T., Kikuchi, H., Motomura, K., Matsushita, T., Ohyagi, Y., & Kira, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.002 · Cited by 44
ALS: Focus on purinergic signalling
Volonté, C., Apolloni, S., Carrì, M. T., & D’Ambrosi, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.002 · Cited by 48
Ginsenoside Re Attenuates Neuroinflammation in a Symptomatic ALS Animal Model
Cai, M., & Yang, E. J. (2016) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x16500233 · Cited by 45
Fontanilla, C. V., Gu, H., Liu, Q., Zhu, T. Z., Zhou, C., Johnstone, B. H., March, K. L., Pascuzzi, R. M., Farlow, M. R., & Du, Y. (2015) · Scientific Reports · doi:10.1038/srep16953 · Cited by 47
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
D’Ambrosi, N., Cozzolino, M., & Carrì, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 47
Mitsui, S., Otomo, A., Nozaki, M., Ono, S., Sato, K., Shirakawa, R., Adachi, H., Aoki, M., Sobue, G., Shang, H., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0373-8 · Cited by 49
Held, A., Major, P., Şahin, A., Reenan, R. A., Lipscombe, D., & Wharton, K. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1771-18.2019 · Cited by 46
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
Gray, E., Thompson, A. G., Wuu, J., Pelt, J., Talbot, K., Benatar, M., & Turner, M. R. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51114 · Cited by 44
Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis
Galbiati, M., Crippa, V., Rusmini, P., Cristofani, R., Messi, E., Piccolella, M., Tedesco, B., Ferrari, V., Casarotto, E., Chierichetti, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124291 · Cited by 48
Mitophagy Modulation, a New Player in the Race against ALS
Madruga, E., Maestro, I., & Martínez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020740 · Cited by 44
Mizuno, H., Warita, H., Aoki, M., & Itoyama, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21702 · Cited by 52
Immune-mediated processes in neurodegeneration: where do we stand?
Fakhoury, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8052-0 · Cited by 43
“For instance, in a study using transgenic mice, reducing the level of SOD1 mutation in microglia slowed the progression of ALS but failed to have significant effects during the early phase of the disease [159].”
BackgroundVarvel, N. H., Espinosa‐García, C., Hunter-Chang, S., Chen, D., Biegel, A., Hsieh, A., Blackmer‐Raynolds, L., Ganesh, T., & Dingledine, R. J. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2040-20.2020 · Cited by 49
Microglia Cell Culture: A Primer for the Novice
Witting, A., & Möller, T. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-170-3_4 · Cited by 43
Radovanović, S., Milićev, M., Peric, S., Basta, I., Kostic, V., & Stevic, Z. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.918148 · Cited by 36
Li, Y., Balasubramanian, U., Cohen, D. A., Zhang, P.-W., Mosmiller, E., Sattler, R., Maragakis, N. J., & Rothstein, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118266 · Cited by 45
Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement?
Boucherie, C., & Hermans, E. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21970 · Cited by 48
Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
Lewandowski, S. A., Nilsson, I., Fredriksson, L., Lönnerberg, P., Muhl, L., Zeitelhofer, M., Adzemovic, M. Z., Nichterwitz, S., Lawrence, D. A., Hedlund, E., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1520-2 · Cited by 48
Davis, S. M., Collier, L. A., Leonardo, C. C., Seifert, H. A., Ajmo, C. T., & Pennypacker, K. R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9587-2 · Cited by 44
Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
Rauskolb, S., Dombert, B., & Sendtner, M. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.007 · Cited by 50
The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability
Rozas, P., Bargsted, L., Martínez, F., Hetz, C. A., & Medinas, D. B. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.066 · Cited by 48
Bonifacino, T., Cattaneo, L., Gallia, E., Puliti, A., Melone, M., Provenzano, F., Bossi, S., Musante, I., Usai, C., Conti, F., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.020 · Cited by 44
The inhibition of CTGF/CCN2 activity improves muscle and locomotor function in a murine ALS model
González, D., Rebolledo, D. L., Correa, L. M., Court, F. A., Cerpa, W. F., Lipson, K. E., van Zundert, B., & Brandan, E. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy204 · Cited by 51
Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats
Chen, T., Huang, B., Shi, X., Gao, L., & Huang, C. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0627-9 · Cited by 47
Myung, W., Lee, H., & Kim, H. (2019) · Environment International · doi:10.1016/j.envint.2018.12.042 · Cited by 44
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Chew, S., & Atassi, N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00135 · Cited by 48
LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice
Tan, H., Chen, M., Pang, D., Xia, X., Du, C., Yang, W., Cui, Y., Huang, C., Jiang, W., Bi, D., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0422-6 · Cited by 46
Pham, J., Keon, M., Brennan, S. E., & Saksena, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103464 · Cited by 45
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
Guidotti, G., Scarlata, C., Brambilla, L., & Rossi, D. (2021) · Cells · doi:10.3390/cells10030518 · Cited by 44
Provenzano, F., Nyberg, S., Giunti, D., Torazza, C., Parodi, B., Bonifacino, T., Usai, C., de Rosbo, N. K., Milanese, M., Uccelli, A., et al. (2022) · Cells · doi:10.3390/cells11233923 · Cited by 52
TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies
Morelli, M. B., Amantini, C., Liberati, S., Santoni, M., & Nabissi, M. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990056 · Cited by 46
Xie, M., Pallegar, P. N., Parusel, S., Nguyen, A. T., & Wu, L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00665-w · Cited by 45
Aebischer, J., Moumen, A., Sazdovitch, V., Seilhean, D., Meininger, V., & Raoul, C. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03623.x · Cited by 42
Pagliardini, V., Pagliardini, S., Corrado, L., Lucenti, A., Panigati, L., Bersano, E., Servo, S., Cantello, R., D'Alfonso, S., & Mazzini, L. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.016 · Cited by 42
Neuron–glia interactions underlie ALS-like axonal cytoskeletal pathology
King, A. E., Dickson, T. C., Blizzard, C. A., Woodhouse, A., Foster, S. S., Chung, R. S., & Vickers, J. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.004 · Cited by 42
Giribaldi, F., Milanese, M., Bonifacino, T., Rossi, P. I. A., Prisco, S. D., Pittaluga, A., Tacchetti, C., Puliti, A., Usai, C., & Bonanno, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.018 · Cited by 47
Lin, P.-Y., Simon, S. M., Koh, W. K., Folorunso, O. O., Umbaugh, C. S., & Pierce, A. P. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-43 · Cited by 46
Kanjhan, R., Noakes, P. G., & Bellingham, M. C. (2015) · Neural Plasticity · doi:10.1155/2016/3423267 · Cited by 51
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis
Chen, K. S., Sakowski, S. A., & Feldman, E. L. (2016) · Annals of Neurology · doi:10.1002/ana.24584 · Cited by 44
Neurovascular Aspects of Amyotrophic Lateral Sclerosis
Oliveira, M. C., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., Sanberg, P. R., Voltarelli, J. C., & Garbuzova-Davis, S. N. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00004-1 · Cited by 46
Apolloni, S., Fabbrizio, P., Amadio, S., Napoli, G., Verdile, V., Morello, G., Iemmolo, R., Aronica, E., Cavallaro, S., & Volonté, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01689 · Cited by 42
The Glucocorticoid Receptor Is a Critical Regulator of HIV Latency in Human Microglial Cells
Alvarez-Carbonell, D., Ye, F., Ramanath, N., Dobrowolski, C. N., & Karn, J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9798-1 · Cited by 42
Leyton-Jaimes, M. F., Kahn, J., & Israelson, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904665116 · Cited by 42
Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
Suzuki, N., Akiyama, T., Warita, H., & Aoki, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00194 · Cited by 48
Pathogenic mechanisms underlying spinocerebellar ataxia type 1
Tejwani, L., & Lim, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03520-z · Cited by 44
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 48
Martin, L. J., & Liu, Z. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318158822b · Cited by 42
Kyrargyri, V., Vega‐Flores, G., Gruart, A., Delgado-Garcia, J. M., & Probert, L. (2014) · Glia · doi:10.1002/glia.22756 · Cited by 47
The innate and adaptive immunological aspects in neurodegenerative diseases
Rodrigues, M. C. O., Sanberg, P. R., Cruz, L. E. G., & Garbuzova-Davis, S. N. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.020 · Cited by 48
Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutase
Tokuda, E., Brännström, T., Andersen, P. M., & Marklund, S. L. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0274-y · Cited by 41
Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
Kishinevsky, A. C. S., & Lou, J. K. I. W. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.s10-007 · Cited by 45
Patin, F., Baranek, T., Vourc’h, P., Nadal‐Desbarats, L., Goossens, J., Marouillat, S., Dessein, A., Descat, A., Hounoum, B. M., Bruno, C., et al. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0461-3 · Cited by 46
Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis
Serio, A., & Patani, R. (2017) · Stem Cells · doi:10.1002/stem.2758 · Cited by 44
Modeling Motor Neuron Resilience in ALS Using Stem Cells
Allodi, I., Nijssen, J., Benitez, J. A., Schweingruber, C., Fuchs, A., Bonvicini, G., Cao, M., Kiehn, O., & Hedlund, E. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.04.009 · Cited by 44
Microglia as therapeutic targets after neurological injury: strategy for cell therapy
Scott, M. C., Bedi, S. S., Olson, S. D., Sears, C. M., & Cox, C. S. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1934447 · Cited by 46
Redox Modifier Genes and Pathways in Amyotrophic Lateral Sclerosis
Carter, B. J., Anklesaria, P., Choi, S., & Engelhardt, J. F. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2414 · Cited by 41
Lee, J. C., Seong, J., Kim, S. H., Lee, S. J., Cho, Y. J., An, J., Nam, D., Joo, K. M., & Ik, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.026 · Cited by 42
Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Fontanilla, C., Wei, X., Zhao, L., Johnstone, B., Pascuzzi, R., Farlow, M., & Du, Y.-S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.025 · Cited by 41
He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 44
Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects
Bozik, M. E., Mather, J. L., Kramer, W. G., Gribkoff, V. K., & Ingersoll, E. W. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010379412 · Cited by 47
E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity
Mishra, A., Maheshwari, M., Chhangani, D., Fujimori-Tonou, N., Endo, F., Joshi, A. P., Jana, N. R., & Yamanaka, K. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.016 · Cited by 40
Self-citationde Oliveira, G. P., Alves, C. J., & Chadi, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00216 · Cited by 44
UNC13A confers risk for sporadic ALS and influences survival in a Spanish cohort
Vidal-Taboada, J. M., López-López, A., Salvadó, M., Lorenzo-Sanz, L., García, C. B., Mahy, N., Rodríguez, M. J., & Gámez, J. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7843-z · Cited by 45
Kaus, A. S., & Sareen, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00448 · Cited by 45
Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis
Chen, X., Chen, Y., Wei, Q., Ou, R., Cao, B., Zhao, B., & Shang, H. (2016) · BMC Neurology · doi:10.1186/s12883-016-0689-x · Cited by 43
How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis
Crabé, R., Aimond, F., Gosset, P., Scamps, F., & Raoul, C. (2020) · Cells · doi:10.3390/cells9122550 · Cited by 41
Lee, J. K., Shin, J. H., Gwag, B. J., & Choi, E. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.009 · Cited by 43
Yin, H. Z., Tang, D. T., & Weiss, J. H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.011 · Cited by 40
Lewis, C. B., Solomon, J. N., Rossi, F. M., & Krieger, C. (2009) · Glia · doi:10.1002/glia.20859 · Cited by 40
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.